Substituted pyridines as inhibitors of histone deacetylase
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g,. HDAC2).
1. A method for treating a cognitive function disorder, a cognitive function impairment, or a psychiatric disorder in a subject in need thereof, wherein the method comprises administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:
or a pharmaceutically acceptable salt of any of the foregoing.
2. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
3. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
4. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
5. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
6. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
7. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
8. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
9. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.
10. The method of claim 1 , wherein the compound is:
or a pharmaceutically acceptable salt thereof.